首页> Clinical and translational science> Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker-driven precision dosing.

Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker-driven precision dosing.

导出 OA

翻译打印收藏纠错

第一作者： Akinyemi,Oni-Orisan

第一单位： Department of Clinical Pharmacy, University of California, San Francisco, California, USA.;Institute for Human Genetics, University of California, San Francisco, California, USA.;Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.

作者： Akinyemi,Oni-Orisan ^[1] ; Nithya,Srinivas ^[2] ; Krina,Mehta ^[3] ; Jesmin Lohy,Das ^[4] ; Thu T,Nguyen ^[5] ; Geoffrey H,Tison ^[6] ; Scott R,Bauer ^[7] ; Maria,Burian ^[8] ; Ryan S,Funk ^[9] ; Richard A,Graham ^[10] ; Biomarkers and Translational Tools Community Working Group of the American Society for Clinical Pharmacology and Therapeutics

作者单位： Department of Clinical Pharmacy, University of California, San Francisco, California, USA.;Institute for Human Genetics, University of California, San Francisco, California, USA.;Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA. ^[1] Incyte Corporation, Wilmington, Delaware, USA. ^[2] qPharmetra, Cary, North Carolina, USA. ^[3] Janssen Pharmaceuticals, Raritan, New Jersey, USA. ^[4] Department of Family and Community Medicine, University of California, San Francisco, California, USA. ^[5] Division of Cardiology, University of California, San Francisco, California, USA. ^[6] Department of Medicine, University of California, San Francisco, California, USA.;Department of Urology, University of California, San Francisco, California, USA.;Veterans Affairs Medical Center, San Francisco, California, USA. ^[7] Translational Medicine Neuroscience, UCB Biopharma SRL, Braine-l'Alleud, Belgium. ^[8] Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, Kansas, USA. ^[9] Theravance Biopharma, South San Francisco, California, USA. ^[10]

医学主题词剂量效应关系, 药物(Dose-Response Relationship, Drug);电子健康病历(Electronic Health Records);人类(Humans);治疗结果(Treatment Outcome)

DOI 10.1111/cts.12973

PMID 33421282

发布时间 2022-01-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交